Outcome-First Project Design
We begin with the decision, approval, launch or investment objective and work backward to identify the required workstreams.
Why work with Ziva DRA
Regulatory strategy built around the business decision.
Ziva DRA brings regulatory affairs, clinical research, market intelligence, global market access and business compliance into one connected advisory framework—helping healthcare and life-science companies move from fragmented requirements toward clearer, executable market-entry decisions.
The Ziva DRA difference
Regulatory success is usually a systems problem.
A submission can depend on technical documentation, manufacturer readiness, evidence, local representation, business structure, commercial feasibility and timing. Ziva DRA is designed around those connections.
The real question is often not “Which service do we need?” but “What must happen before this product or investment can enter the market responsibly?”
Common riskFragmented requirements
→Coordinate regulatory, clinical, market and business requirements within one project architecture.
Common riskHidden readiness gaps
→Identify missing evidence, documents and dependencies before major execution costs are incurred.
Common riskActivity without direction
→Work backward from the approval, launch, investment or decision objective.
Common riskRegulatory tunnel vision
→Consider commercial feasibility and Bangladesh market realities where they affect the investment.
Why companies choose Ziva DRA
Six principles behind every engagement.
Our role is to create clarity where regulatory, technical and commercial requirements intersect—then help the project move forward in the right sequence.
Connected Regulatory Thinking
Registration, evidence, documentation, representation and business compliance are treated as connected components.
Early Gap Identification
Critical gaps are surfaced before large execution costs are incurred, while they remain more manageable.
Commercially Aware Regulation
Market intelligence can be integrated where commercial alignment materially affects the regulatory investment.
Bangladesh Market Context
Advice reflects the local regulatory, operating, business and commercial environment international teams must navigate.
Multi-Disciplinary Capability
Regulatory, clinical, market-access, intelligence and compliance expertise can operate around one objective.
How we approach projects
From uncertainty to a structured workplan.
A disciplined sequence helps ensure execution begins only after the project has been sufficiently understood.
DefineClarify the product, business objective and decision point.
AssessReview available information, documents and current readiness.
MapIdentify dependencies across regulatory, clinical and business areas.
PrioritizeSequence critical workstreams and resolve blockers first.
AdvanceMove into execution with a clearer regulatory and business path.
Integrated capability
Five capabilities. One project system.
A client can engage one focused service area or combine multiple capabilities around a broader strategic objective.
View all services →Regulatory Affairs
Product registration, regulatory strategy, documentation readiness and local compliance support.
Clinical Research
Scientific and evidence-development workstreams supporting regulatory and product programs.
Market Intelligence
Commercial intelligence surrounding regulatory and market-entry investment decisions.
Global Market Access
Strategic support for manufacturers evaluating Bangladesh and other regulated markets.
Business Compliance
Corporate and operating structures behind regulated-product and healthcare market entry.
Project Integration
Dependency mapping, workstream prioritization and decision-oriented reporting around a single objective.
How we think
Precision, clarity and disciplined restraint.
What clients should expect
- Clear definition of the project objective
- Identification of missing information and dependencies
- Separation of assumptions from verified facts
- Practical next-step recommendations within scope
- Commercial context where it is relevant
What we avoid
- Assuming one pathway applies to every product
- Treating registration separately from readiness
- Ignoring feasibility where it affects investment
- Presenting general guidance as a determination
- Advancing while material gaps remain unclear
Need more than a standard regulatory service?
Share your product, company, target market, documentation status and current challenge. We’ll help define the actual project problem.